CN115348871B - 填充于树脂制容器的含银盐的眼科用水性组合物 - Google Patents

填充于树脂制容器的含银盐的眼科用水性组合物

Info

Publication number
CN115348871B
CN115348871B CN202180026304.3A CN202180026304A CN115348871B CN 115348871 B CN115348871 B CN 115348871B CN 202180026304 A CN202180026304 A CN 202180026304A CN 115348871 B CN115348871 B CN 115348871B
Authority
CN
China
Prior art keywords
aqueous composition
ophthalmic aqueous
ophthalmic
aqueous
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202180026304.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN115348871A (zh
Inventor
桃川雄介
饭田真希
浅田博之
藤泽丰实
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of CN115348871A publication Critical patent/CN115348871A/zh
Application granted granted Critical
Publication of CN115348871B publication Critical patent/CN115348871B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Bridges Or Land Bridges (AREA)
CN202180026304.3A 2020-03-31 2021-02-26 填充于树脂制容器的含银盐的眼科用水性组合物 Active CN115348871B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020-062252 2020-03-31
JP2020062252 2020-03-31
PCT/JP2021/007366 WO2021199814A1 (ja) 2020-03-31 2021-02-26 樹脂製容器に充填された銀塩含有眼科用水性組成物

Publications (2)

Publication Number Publication Date
CN115348871A CN115348871A (zh) 2022-11-15
CN115348871B true CN115348871B (zh) 2025-08-08

Family

ID=77930318

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180026304.3A Active CN115348871B (zh) 2020-03-31 2021-02-26 填充于树脂制容器的含银盐的眼科用水性组合物

Country Status (8)

Country Link
US (1) US20230145529A1 (enExample)
EP (1) EP4129341A4 (enExample)
JP (4) JP7053966B2 (enExample)
KR (2) KR102705675B1 (enExample)
CN (1) CN115348871B (enExample)
CA (1) CA3176584A1 (enExample)
TW (1) TWI896607B (enExample)
WO (1) WO2021199814A1 (enExample)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050072883A (ko) * 2004-01-07 2005-07-12 뉴바이오 (주) 4차암모늄의 공중합에 의한 콘택트렌즈제조방법
CN105228630A (zh) * 2013-02-15 2016-01-06 千寿制药株式会社 含抗微生物金属的二氟泼尼酯乳液组合物
JP2016179960A (ja) * 2015-03-24 2016-10-13 ロート製薬株式会社 眼科用組成物
WO2019107569A1 (ja) * 2017-12-01 2019-06-06 参天製薬株式会社 眼科用製品
WO2020004247A1 (ja) * 2018-06-28 2020-01-02 株式会社Ｃｓｐアドバンスソリューションズ 流行性角結膜炎の治療用点眼剤、当該点眼剤を生成するプラズマ活性点眼剤生成装置、及び流行性角結膜炎の治療方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
JP4683835B2 (ja) * 2003-12-01 2011-05-18 ロート製薬株式会社 防腐剤及びこれを含有する水性組成物
JP4856392B2 (ja) 2004-04-23 2012-01-18 ロート製薬株式会社 防腐剤及びこれを含有する水性組成物
JP2006162648A (ja) 2004-12-02 2006-06-22 Konica Minolta Business Technologies Inc 現像装置及び画像形成装置
BRPI0818459A2 (pt) * 2007-10-16 2015-04-14 Sun Pharma Advanced Res Co Ltd Composição farmacêutica adequada para uso oftálmico.
IN2014MN01555A (enExample) * 2012-02-27 2015-07-03 Rohto Pharma
US20160022648A1 (en) * 2013-03-13 2016-01-28 Santen Pharmaceutical Co., Ltd. Therapeutic agent for meibomian gland dysfunction
SG11201705138QA (en) * 2014-12-25 2017-07-28 Santen Pharmaceutical Co Ltd Aqueous ophthalmic solution
TWI711453B (zh) 2015-06-05 2020-12-01 日商參天製藥股份有限公司 抑制水性點眼液中之洛赫西定類的殘存率降低之方法
JP6615548B2 (ja) * 2015-08-06 2019-12-04 ロート製薬株式会社 眼科組成物
JP7139206B2 (ja) 2018-09-21 2022-09-20 小林製薬株式会社 医薬組成物

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050072883A (ko) * 2004-01-07 2005-07-12 뉴바이오 (주) 4차암모늄의 공중합에 의한 콘택트렌즈제조방법
CN105228630A (zh) * 2013-02-15 2016-01-06 千寿制药株式会社 含抗微生物金属的二氟泼尼酯乳液组合物
JP2016179960A (ja) * 2015-03-24 2016-10-13 ロート製薬株式会社 眼科用組成物
WO2019107569A1 (ja) * 2017-12-01 2019-06-06 参天製薬株式会社 眼科用製品
WO2020004247A1 (ja) * 2018-06-28 2020-01-02 株式会社Ｃｓｐアドバンスソリューションズ 流行性角結膜炎の治療用点眼剤、当該点眼剤を生成するプラズマ活性点眼剤生成装置、及び流行性角結膜炎の治療方法

Also Published As

Publication number Publication date
CN115348871A (zh) 2022-11-15
CA3176584A1 (en) 2021-10-07
JP2025146955A (ja) 2025-10-03
US20230145529A1 (en) 2023-05-11
KR20220161379A (ko) 2022-12-06
WO2021199814A1 (ja) 2021-10-07
JP7169477B2 (ja) 2022-11-10
JP2023001184A (ja) 2023-01-04
JPWO2021199814A1 (enExample) 2021-10-07
JP2022087168A (ja) 2022-06-09
EP4129341A4 (en) 2024-04-24
JP7053966B2 (ja) 2022-04-12
JP7721498B2 (ja) 2025-08-12
KR102705675B1 (ko) 2024-09-11
EP4129341A1 (en) 2023-02-08
KR20240135080A (ko) 2024-09-10
TW202203920A (zh) 2022-02-01
TWI896607B (zh) 2025-09-11

Similar Documents

Publication Publication Date Title
JP6903448B2 (ja) ドルゾラミドとブリモニジンを含む医薬組成物
CN115348871B (zh) 填充于树脂制容器的含银盐的眼科用水性组合物
JP2023093601A (ja) 眼科用製品
CN103379904A (zh) 具有保存效能的溴芬酸水性液剂组合物
US11324829B2 (en) Antiseptic agent comprising meglumine or salt thereof
TW202231276A (zh) 保存效果或光穩定性經改善之眼科藥用組成物
JP6702754B2 (ja) ドルゾラミドを含有する防腐剤
JP7144630B2 (ja) レバミピドまたはその塩および高分子を含有する水性懸濁液
JP6877613B2 (ja) 防腐効果のある医薬の組合せ
TW202404569A (zh) 含有賽佩普斯特(Sepetaprost)之眼科用組合物
HK1257724A1 (en) Pharmaceutical composition including dorzolamide and brimonidine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant